Literature DB >> 29061726

Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.

Kwangseok Hong1, Min Li1, Zahra Nourian1, Gerald A Meininger1, Michael A Hill2.   

Abstract

Studies suggest that arteriolar pressure-induced vasoconstriction can be initiated by GPCRs (G protein-coupled receptors), including the AT1R (angiotensin II type 1 receptor). This raises the question, are such mechanisms regulated by negative feedback? The present studies examined whether RGS (regulators of G protein signaling) proteins in vascular smooth muscle cells are colocalized with the AT1R when activated by mechanical stress or angiotensin II and whether this modulates AT1R-mediated vasoconstriction. To determine whether activation of the AT1R recruits RGS5, an in situ proximity ligation assay was performed in primary cultures of cremaster muscle arteriolar vascular smooth muscle cells treated with angiotensin II or hypotonic solution in the absence or presence of candesartan (an AT1R blocker). Proximity ligation assay results revealed a concentration-dependent increase in trafficking/translocation of RGS5 toward the activated AT1R, which was attenuated by candesartan. In intact arterioles, knockdown of RGS5 enhanced constriction to angiotensin II and augmented myogenic responses to increased intraluminal pressure. Myogenic constriction was attenuated to a higher degree by candesartan in RGS5 siRNA-transfected arterioles, consistent with RGS5 contributing to downregulation of AT1R-mediated signaling. Further, translocation of RGS5 was impaired in vascular smooth muscle cells of spontaneously hypertensive rats. This is consistent with dysregulated (RGS5-mediated) AT1R signaling that could contribute to excessive vasoconstriction in hypertension. In intact vessels, candesartan reduced myogenic vasoconstriction to a greater extent in spontaneously hypertensive rats compared with controls. Collectively, these findings suggest that AT1R activation results in translocation of RGS5 toward the plasma membrane, limiting AT1R-mediated vasoconstriction through its role in Gq/11 protein-dependent signaling.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin II; candesartan; cell membrane; hypertension; rats

Mesh:

Substances:

Year:  2017        PMID: 29061726      PMCID: PMC5683087          DOI: 10.1161/HYPERTENSIONAHA.117.09757

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

Review 1.  Signaling mechanisms underlying the vascular myogenic response.

Authors:  M J Davis; M A Hill
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

2.  Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype.

Authors:  Randolph L Geary; James M Wong; Anthony Rossini; Stephen M Schwartz; Lawrence D Adams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

3.  Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives.

Authors:  Evan L Riddle; Brinda K Rana; Kenton K Murthy; Fangwen Rao; Eleazar Eskin; Daniel T O'Connor; Paul A Insel
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

4.  Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia.

Authors:  Vasyl Holobotovskyy; Yee Seng Chong; Jennifer Burchell; Bo He; Michael Phillips; Leo Leader; Timothy V Murphy; Shaun L Sandow; Douglas J McKitrick; Adrian K Charles; Marianne Tare; Leonard F Arnolda; Ruth Ganss
Journal:  Sci Transl Med       Date:  2015-06-03       Impact factor: 17.956

5.  Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues.

Authors:  Yanbin Liang; Chen Li; Victor M Guzman; William W Chang; Albert J Evinger; Dyna Sao; David F Woodward
Journal:  FEBS J       Date:  2005-02       Impact factor: 5.542

Review 6.  Cellular regulation of RGS proteins: modulators and integrators of G protein signaling.

Authors:  Susanne Hollinger; John R Hepler
Journal:  Pharmacol Rev       Date:  2002-09       Impact factor: 25.468

Review 7.  Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Trends Cardiovasc Med       Date:  2013-08-17       Impact factor: 6.677

8.  Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure.

Authors:  K Mary Tang; Guang-rong Wang; Ping Lu; Richard H Karas; Mark Aronovitz; Scott P Heximer; Kevin M Kaltenbronn; Kendall J Blumer; David P Siderovski; Yan Zhu; Michael E Mendelsohn; Mary Tang; Guang Wang
Journal:  Nat Med       Date:  2003-11-09       Impact factor: 53.440

9.  Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.

Authors:  Vasyl Holobotovskyy; Mitali Manzur; Marianne Tare; Jennifer Burchell; Erin Bolitho; Helena Viola; Livia C Hool; Leonard F Arnolda; Douglas J McKitrick; Ruth Ganss
Journal:  Circ Res       Date:  2013-01-09       Impact factor: 17.367

10.  Renal AT1 receptor protein expression during the early stage of diabetes mellitus.

Authors:  Lisa M Harrison-Bernard; John D Imig; Pamela K Carmines
Journal:  Int J Exp Diabetes Res       Date:  2002 Apr-Jun
View more
  8 in total

Review 1.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

2.  Enhanced Myogenic Constriction in the SHR Preglomerular Vessels Is Mediated by Thromboxane A2 Synthesis.

Authors:  Samera Nademi; Chao Lu; Jeffrey G Dickhout
Journal:  Front Physiol       Date:  2020-07-22       Impact factor: 4.566

Review 3.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 4.  The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor.

Authors:  Gábor Turu; András Balla; László Hunyady
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

5.  The dopamine receptor D5 gene shows signs of independent erosion in toothed and baleen whales.

Authors:  Luís Q Alves; Juliana Alves; Rodrigo Ribeiro; Raquel Ruivo; Filipe Castro
Journal:  PeerJ       Date:  2019-10-11       Impact factor: 2.984

6.  Short stature and combined immunodeficiency associated with mutations in RGS10.

Authors:  Ivan K Chinn; Zhihui Xie; Eunice C Chan; Bianca M Nagata; Alexey Koval; Wei-Sheng Chen; Fan Zhang; Sundar Ganesan; Diana N Hong; Motoshi Suzuki; Glenn Nardone; Ian N Moore; Vladimir L Katanaev; Andrea E Balazs; Chengyu Liu; James R Lupski; Jordan S Orange; Kirk M Druey
Journal:  Sci Signal       Date:  2021-07-27       Impact factor: 9.517

7.  Nox2 signaling and muscle fiber remodeling are attenuated by losartan administration during skeletal muscle unloading.

Authors:  Jeffrey M Hord; Marcela M Garcia; Katherine R Farris; Vinicius Guzzoni; Yang Lee; Matthew S Lawler; John M Lawler
Journal:  Physiol Rep       Date:  2021-01

8.  A regulator of G protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease.

Authors:  Ya-Kun Gao; Rui-Juan Guo; Xin Xu; Xiao-Fu Huang; Yu Song; Dan-Dan Zhang; Ning Chen; Xiao-Wei Wang; Chen-Xi Liang; Peng Kong; Mei Han
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.